was read the article
array:23 [ "pii" => "S1578219012002752" "issn" => "15782190" "doi" => "10.1016/j.adengl.2012.01.017" "estado" => "S300" "fechaPublicacion" => "2012-11-01" "aid" => "572" "copyright" => "Elsevier España, S.L. and AEDV" "copyrightAnyo" => "2011" "documento" => "article" "crossmark" => 0 "subdocumento" => "ssu" "cita" => "Actas Dermosifiliogr. 2012;103:778-83" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3849 "formatos" => array:3 [ "EPUB" => 44 "HTML" => 2682 "PDF" => 1123 ] ] "itemSiguiente" => array:19 [ "pii" => "S157821901200337X" "issn" => "15782190" "doi" => "10.1016/j.adengl.2011.10.005" "estado" => "S300" "fechaPublicacion" => "2012-11-01" "aid" => "586" "copyright" => "Elsevier España, S.L. and AEDV" "documento" => "article" "crossmark" => 0 "subdocumento" => "ssu" "cita" => "Actas Dermosifiliogr. 2012;103:784-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2867 "formatos" => array:3 [ "EPUB" => 44 "HTML" => 1998 "PDF" => 825 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "In vivo reflectance confocal microscopy for early diagnosis of nonmelanoma skin cancer" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "784" "paginaFinal" => "789" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "La microscopía confocal de reflectancia in vivo para el diagnóstico precoz del cáncer de piel no melanoma" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2277 "Ancho" => 1667 "Tamanyo" => 461559 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Correlation of clinical, dermoscopic, and reflectance confocal microscopy (RCM) images of a cystic basal cell carcinoma (BCC). (A) Clinical image of the lesion showing severe actinic damage with multiple actinic keratoses. On the right cheek a small skin-colored papule is observed (white arrow). (B) Dermatoscopic image of the lesion showing some telangiectasias around the papule. (C) RCM horizontal mosaic (4<span class="elsevierStyleHsp" style=""></span>mm<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>4<span class="elsevierStyleHsp" style=""></span>mm) obtained at the level of the superficial dermis showing multiple, round hyporefractile and non-refractile areas in a lobular arrangement (red circle). (D) Single RCM image (0.5<span class="elsevierStyleHsp" style=""></span>mm<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>0.5<span class="elsevierStyleHsp" style=""></span>mm) showing tumor islands with bright homogeneous centers surrounded by large dark clefts (white asterisk). (E) Histopathologic correlate showing a cystic variant of a BCC with basaloid tumor cells arranged in nests. Areas of mucin deposition (white asterisk) can be observed surrounding the tumor islands and forming cystic spaces (black asterisk).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Ulrich, S. Lange-Asschenfeldt, S. González" "autores" => array:3 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Ulrich" ] 1 => array:2 [ "nombre" => "S." "apellidos" => "Lange-Asschenfeldt" ] 2 => array:2 [ "nombre" => "S." "apellidos" => "González" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0001731012001202" "doi" => "10.1016/j.ad.2011.10.017" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731012001202?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901200337X?idApp=UINPBA000044" "url" => "/15782190/0000010300000009/v1_201304241357/S157821901200337X/v1_201304241357/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S1578219012002740" "issn" => "15782190" "doi" => "10.1016/j.adengl.2011.10.001" "estado" => "S300" "fechaPublicacion" => "2012-11-01" "aid" => "528" "copyright" => "Elsevier España, S.L. and AEDV" "documento" => "article" "crossmark" => 0 "subdocumento" => "ssu" "cita" => "Actas Dermosifiliogr. 2012;103:762-77" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5561 "formatos" => array:3 [ "EPUB" => 47 "HTML" => 4549 "PDF" => 965 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Dermatofibrosarcoma Protuberans" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "762" "paginaFinal" => "777" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Dermatofibrosarcoma protuberans" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1882 "Ancho" => 2502 "Tamanyo" => 344663 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Clinical images of dermatofibrosarcoma. A, Dermatofibrosarcoma in the left frontal region in the form of a plaque. B, Dermatofibrosarcoma in the supraclavicular region with surface nodules. C, Dermatofibrosarcoma on the chest with the appearance of a scarred plaque. D, Dermatofibrosarcoma in the supraclavicular region with surface nodules.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Serra-Guillén, B. Llombart, O. Sanmartín" "autores" => array:3 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Serra-Guillén" ] 1 => array:2 [ "nombre" => "B." "apellidos" => "Llombart" ] 2 => array:2 [ "nombre" => "O." "apellidos" => "Sanmartín" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219012002740?idApp=UINPBA000044" "url" => "/15782190/0000010300000009/v1_201304241357/S1578219012002740/v1_201304241357/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review Article</span>" "titulo" => "Update on the Treatment of Superficial Mycoses" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "778" "paginaFinal" => "783" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "M. Pereiro Ferreirós, F.J. García-Martínez, J. Alonso-González" "autores" => array:3 [ 0 => array:5 [ "nombre" => "M." "apellidos" => "Pereiro Ferreirós" "sufijo" => "Jr." "email" => array:1 [ 0 => "manuel.pereiro.ferreiros@usc.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "F.J." "apellidos" => "García-Martínez" ] 2 => array:2 [ "nombre" => "J." "apellidos" => "Alonso-González" ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Departamento de Dermatología, Complejo Hospitalario Universitario, Facultad de Medicina, Universidad de Santiago de Compostela, La Coruña, Spain" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresonding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Actualización en el tratamiento de las micosis cutáneas" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Treatment review articles usually focus on recently investigated drugs. However, these new drugs are sometimes of little use in routine clinical practice because they are not first-line options. In Spain, as in the rest of Europe, the most common mycoses are pityriasis versicolor,<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> the various clinical forms of dermatophytosis,<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2–4</span></a> and candidiasis. In this review of current treatments, we focus on these 3 groups of mycoses and their first-line treatments.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Our aim is to answer several questions: Are any new treatments available for superficial mycoses? Are new treatments needed, or are the conventional treatments adequate? And finally, do we make good use of the available resources, or do we need to be more efficient in our treatment of superficial mycoses?</p><p id="par0015" class="elsevierStylePara elsevierViewall">What is needed, we believe, is not merely a list of recently developed treatments but a review of ways to improve clinical outcomes through the proper use of conventional drugs. We also believe that costs can be reduced without sacrificing outcome quality.</p><p id="par0020" class="elsevierStylePara elsevierViewall">We draw on our personal experience as well as evidence from 3 types of publications: experimental research, clinical trials, and pharmacoeconomic studies.</p><p id="par0025" class="elsevierStylePara elsevierViewall">In routine clinical practice, the treatment of superficial mycoses with antifungals differs from that of infections treated with antibiotic therapy in that susceptibility testing is only useful in infections caused by <span class="elsevierStyleItalic">Candida</span> organisms.<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5,6</span></a> In the case of other yeasts, such as <span class="elsevierStyleItalic">Malassezia</span><a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> and dermatophytes,<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> susceptibility tests are difficult to perform, poorly standardized, and purely of academic interest.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Available Treatments Are Well Known But Poorly Used</span><p id="par0030" class="elsevierStylePara elsevierViewall">Since the appearance of griseofulvin and the polyenes in the 1950s, the pharmacopeia for superficial mycoses has seen the addition of topical treatments, such as the azoles, ciclopirox, and amorolfine as well as the oral triazoles and allylamines. Around 60 new antifungal substances are currently being investigated. These include new formulations and semisynthetic derivatives of polyenes and amphotericin, new peptides such as echinocandins and aerothricines, and novel substances such as amino acids, sordarins, macrolides, terpenes, saponins, and flavans.<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9,10</span></a> Although many of these drugs have been tested against dermatophytes in the laboratory, the specialized products that have been brought to market are expensive and are not indicated for superficial mycoses, except in extreme cases or in a hypothetical future.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">Moreover, despite the large number of clinical trials of antifungal agents conducted over recent decades, we found that the meta-analyses on this topic include a strikingly small number of trials, suggesting a lack of homogeneity in the methodologies used.<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">12–14</span></a> Review articles on this subject therefore invariably conclude by indicating that further studies are needed in the field of superficial mycoses.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a></p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">How Much Is Being Spent on Antifungal Agents in Spain?</span><p id="par0040" class="elsevierStylePara elsevierViewall">A similar situation can be seen in pharmacoeconomic studies on antifungal agents. The results of these studies vary greatly depending on their objectives (cost-effectiveness, cost-utility, cost-benefit), the sponsoring institution (public body or private company), time frame and geographic scope, type of cost evaluated (only the drug or the entire medical intervention), and outcome (cure or disease-free days).<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> Pharmacoeconomic studies identify, one way or another, the least expensive treatment, but they do not clearly demonstrate the importance of choosing the least expensive option.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">We requested data from the Spanish Ministry of Health for 2001, a year in which a complete census of Spain's population was conducted (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). According to the data provided, 1 package of topical antifungal agent was used for every 4 people and 1 package of oral antifungal agent was used for every 24 people in the country in 2001. Although a more in-depth analysis is warranted,<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a> these data clearly suggest that antifungal agents are being overused in Spain.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0050" class="elsevierStylePara elsevierViewall">Recent studies of superficial mycoses have focused primarily on the best use of known resources,<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a> and on the search for efficacy enhancers, such as adjuvant therapies, for both topical and oral treatments.<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">19,20</span></a></p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">First-Line Treatments and Practical Aspects</span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Griseofulvin</span><p id="par0055" class="elsevierStylePara elsevierViewall">For more than 40 years, griseofulvin has been the first-line treatment for ringworm of the scalp in pediatric patients (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).<a class="elsevierStyleCrossRefs" href="#bib0105"><span class="elsevierStyleSup">21–23</span></a> In that setting, griseofulvin is more effective than fluconazole and just as effective as itraconazole and terbinafine<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">24</span></a> but much less expensive. The rate of adverse effects associated with griseofulvin is low and does not increase at high doses (15-20<span class="elsevierStyleHsp" style=""></span>mg/kg/d in children).<a class="elsevierStyleCrossRefs" href="#bib0100"><span class="elsevierStyleSup">20,21</span></a> Current guidelines recommend continuing griseofulvin treatment for at least 6 weeks at a dose adjusted to body weight: in children weighing <span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleHsp" style=""></span>kg, the dose should not exceed 250<span class="elsevierStyleHsp" style=""></span>mg/d; in patients weighing 10 to 20<span class="elsevierStyleHsp" style=""></span>kg, the recommended dose is 375<span class="elsevierStyleHsp" style=""></span>mg/d; in patients weighing 20 to 40<span class="elsevierStyleHsp" style=""></span>kg, 500<span class="elsevierStyleHsp" style=""></span>mg/d; and in patients weighing ><span class="elsevierStyleHsp" style=""></span>40<span class="elsevierStyleHsp" style=""></span>kg, 1000<span class="elsevierStyleHsp" style=""></span>mg/d. Because the half-life of the drug is less than 24<span class="elsevierStyleHsp" style=""></span>hours, the guidelines recommend administering the daily dose in 2 doses.<a class="elsevierStyleCrossRefs" href="#bib0100"><span class="elsevierStyleSup">20,21</span></a></p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0060" class="elsevierStylePara elsevierViewall">Imported cases of ringworm caused by <span class="elsevierStyleItalic">Trichophyton tonsurans</span> may be resistant to griseofulvin and require treatment with terbinafine. The likelihood of adverse reactions is very low and this possibility should only be taken into consideration in patients with a history of serious adverse reactions to other drugs.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a></p><p id="par0065" class="elsevierStylePara elsevierViewall">The efficacy of griseofulvin can be improved significantly by the simultaneous ingestion of fatty foods, which stabilize the gastric pH, and by the application of fomentations because local heat and moisture cause sweating, which in turn enhances the transcutaneous excretion of the drug.<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">21</span></a></p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Oral Triazoles</span><p id="par0070" class="elsevierStylePara elsevierViewall">Fluconazole is the first-line treatment for recurrent cases of oropharyngeal and genital candidiasis<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">25</span></a> that respond poorly to topical treatments, and for severe subcutaneous and systemic mycoses (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).<a class="elsevierStyleCrossRefs" href="#bib0130"><span class="elsevierStyleSup">26,27</span></a> It is the third-line treatment for tinea infections that affect terminal hair and/or the nails (onychomycosis) in adults. Failed candidiasis treatments are more often associated with incorrect administration than with resistance.<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">18,19</span></a> The treatment of candidiasis should always be accompanied by dietary and hygiene measures, ranging from conventional iron metabolism monitoring to changes in eating habits.<a class="elsevierStyleCrossRefs" href="#bib0125"><span class="elsevierStyleSup">25,28</span></a> Itraconazole could be considered the German Shepherd of oral antifungal agents because it is second-best at nearly everything. It is better than terbinafine, though not as effective as griseofulvin, in the treatment of mycoses caused by <span class="elsevierStyleItalic">Microsporum canis</span>. It is the first-line monotherapy for extensive pityriasis versicolor (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). Itraconazole is also used to reduce the cost of switch therapy for onychomycosis, as will be explained below (<a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>). The pharmacokinetic problems of itraconazole will probably be improved in the new formulation that is currently being tested.<a class="elsevierStyleCrossRefs" href="#bib0145"><span class="elsevierStyleSup">29,30</span></a></p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Topical Azoles</span><p id="par0075" class="elsevierStylePara elsevierViewall">The topical azoles are a large, well-known group of substances to which new products are continually being added. Topical azole treatments are cheap, potent, and broad-spectrum, with activity against dermatophytes, molds, and yeasts (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). The absorption and, therefore, the effectiveness of topical azoles can be increased with the application of occlusive dressings. The use of topical azoles in combination with topical corticosteroids has been recommended in the treatment of inflammatory tineas. The addition of a topical corticosteroid enhances efficacy by decreasing the inflammatory component, facilitating the restoration of the skin's barrier function and normal flora, and diminishing the Herxheimer reaction that sometimes occurs at the start of treatment.<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">31</span></a> This combination should not be used to treat tineas caused by anthropophilic fungi because in such cases it can lead to the development of tinea incognito and Majocchi granulomas.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a></p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Allylamines</span><p id="par0080" class="elsevierStylePara elsevierViewall">In adults, single-drug therapy with oral terbinafine is the first-line treatment for onychomycosis and extensive tineas that respond poorly to topical treatment (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). In children, the use of oral terbinafine is limited to patients over 2 years of age with griseofulvin-resistant cases of <span class="elsevierStyleItalic">T tonsurans</span>. A regimen of 6 weeks is recommended for infections of the scalp or fingernails and of 12 weeks for onychomycosis of the toenails. The recommended regimen in the United States, which is based on the availability of scored 125<span class="elsevierStyleHsp" style=""></span>mg tablets, calls for <span class="elsevierStyleItalic">a)</span> half a tablet daily for children weighing under 20<span class="elsevierStyleHsp" style=""></span>kg, <span class="elsevierStyleItalic">b)</span> 1 tablet daily for children weighing 20 to 40<span class="elsevierStyleHsp" style=""></span>kg, and <span class="elsevierStyleItalic">c)</span> 1 tablet twice daily for children weighing over 40<span class="elsevierStyleHsp" style=""></span>kg.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a></p><p id="par0085" class="elsevierStylePara elsevierViewall">In Spain, oral terbinafine is sold in scored 250<span class="elsevierStyleHsp" style=""></span>mg tablets and cannot therefore be prescribed to children weighing under 20<span class="elsevierStyleHsp" style=""></span>kg.<a class="elsevierStyleCrossRefs" href="#bib0070"><span class="elsevierStyleSup">14,20,24</span></a> The role of oral terbinafine in switch therapy for onychomycosis is discussed below.</p><p id="par0175" class="elsevierStylePara elsevierViewall">Topical terbinafine is the topical antifungal agent most effective against tinea pedis in young adults (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>); however, because it is more expensive than azoles, this drug has been relegated to the role of a rescue medication.<a class="elsevierStyleCrossRefs" href="#bib0160"><span class="elsevierStyleSup">32–34</span></a></p><p id="par0090" class="elsevierStylePara elsevierViewall">Concerns regarding resistance in cases of <span class="elsevierStyleItalic">M canis</span> infection are inconsequential because infections caused by this microorganism tend to respond very well to griseofulvin.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a></p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Morpholines and Ciclopirox</span><p id="par0095" class="elsevierStylePara elsevierViewall">Morpholines and ciclopirox are highly potent broad-spectrum drugs capable of penetrating both glabrous skin and nail plates. They are effective as monotherapy against white superficial onychomycosis and athlete's foot in older patients who are already taking multiple medications. They are also useful in switch therapy (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). There have been reports of irritant reactions to these drugs, although most of these have been associated with excipients.<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">35</span></a></p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Polyenes (Nystatin)</span><p id="par0100" class="elsevierStylePara elsevierViewall">Nystatin is highly effective against candidiasis of both the skin and the mucous membranes, even in cases that are resistant to fluconazole and all other azoles.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">36</span></a> Because of its good safety profile and the fact that most patients tolerate it well, nystatin is recommended for prolonged treatment (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). In the United States, there have been reports of contact dermatitis associated with the topical excipients used in certain generic preparations.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a></p></span></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Recommendations for Reducing the Duration of Oral Treatment</span><p id="par0105" class="elsevierStylePara elsevierViewall">Like the use of occlusive dressings, mentioned above, the use of switch therapy can significantly reduce the duration of systemic antifungal treatment. Switch therapy is particularly useful in elderly, immunodeficient, or polymedicated patients with onychomycosis or extensive mycosis of the terminal hair or glabrous skin. In switch therapy, topical antifungal treatment is initiated prior to the start of oral treatment.<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">13,18–20,29</span></a></p><p id="par0110" class="elsevierStylePara elsevierViewall">In patients with onychomycosis, the following procedure is recommended. Specimens should be obtained for direct examination and culture and a topical antifungal lacquer, to be applied once daily for 1 month, should be prescribed. After 1 month, depending on the results of the direct examination and culture, oral treatment may be initiated. Topical treatment should be enhanced by using fomentations or hand or foot baths to increase the permeability of the nail plate.<a class="elsevierStyleCrossRefs" href="#bib0145"><span class="elsevierStyleSup">29,30,37,38</span></a></p><p id="par0115" class="elsevierStylePara elsevierViewall">The use of imidazole shampoo for at least 15 days prior to the start of a 7-day regimen of oral itraconazole can be effective against mycoses affecting hair-bearing areas as well as extensive pityriasis versicolor.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a></p><p id="par0120" class="elsevierStylePara elsevierViewall">In ringworm of the scalp, griseofulvin should be used at high doses for 6 weeks. The response rate increases considerably with the addition of fomentations and topical imidazole in a cream, solution, or shampoo.<a class="elsevierStyleCrossRefs" href="#bib0100"><span class="elsevierStyleSup">20,24</span></a> Noninflammatory trichophytic tineas in adults are treated with a continuous 1-month regimen of oral terbinafine plus the topical treatment described above (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">24</span></a></p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Cost-Effectiveness in Specific Situations</span><p id="par0125" class="elsevierStylePara elsevierViewall">The most effective topical monotherapies for tineas, inflammatory or not, affecting hairless, glabrous, and inguinal skin in young adults are terbinafine and ciclopirox, while the least expensive are tolnaftate and undecylenic acid, both available in various presentations. However, we believe that topical azoles should be the first-line treatment because their efficacy is similar to that of terbinafine and ciclopirox but they are less expensive (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). In order to increase drug penetration and effectiveness, shorten treatment duration, and prevent recurrence, the use of occlusive dressings, fomentations, and hand and foot baths is essential.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a></p><p id="par0130" class="elsevierStylePara elsevierViewall">As noted above, combination therapy with an azole and a topical corticosteroid is especially useful at the start of treatment against inflammatory ringworm, in the event of a Herxheimer reaction,<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">31</span></a> and in patients who, on completion of treatment, present eczematous or irritative symptoms.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a></p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Switch Therapy in Onychomycosis</span><p id="par0135" class="elsevierStylePara elsevierViewall">Switch therapy is the first-line treatment approach in onychomycosis.<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9,13</span></a> The drugs used in a switch therapy regimen can be administered in different sequences, with little impact on the final efficacy but large variations in cost. It is important to focus not on the cost of treating a single patient but on the expenditure of a large group of doctors over many years. <a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a> shows the final cost for 500 000 patients of 2 regimens of similar efficacy, 1 significantly less expensive than the other.<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">39</span></a></p><p id="par0140" class="elsevierStylePara elsevierViewall">Another approach that reduces the cost of treating onychomycosis is oral pulse therapy, a method first used in the 1960s with griseofulvin.<a class="elsevierStyleCrossRefs" href="#bib0200"><span class="elsevierStyleSup">40,41</span></a> At present, pulse therapy with terbinafine is considered to be similar to continuous therapy in terms of efficacy and safety. The recommended regimens range from 500<span class="elsevierStyleHsp" style=""></span>mg daily for the first week of each month for 3 months<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">42</span></a> to 500<span class="elsevierStyleHsp" style=""></span>mg daily for the first and third months of a 3-month regimen.<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">43</span></a></p><p id="par0145" class="elsevierStylePara elsevierViewall">Various topical response enhancers aimed at reducing the need for oral therapy in onychomycosis have been proposed.<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">30</span></a> This group includes substances that enhance the penetration of the topical treatment into the nail, such as urea, urea hydrogen peroxide, salicylic acid, thioglycolic acid, acetylcysteine, 2-mercaptoethanol, 2-nonyl-1,3-dioxolane, keratinases, and phosphoric acid.<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">29</span></a> Other methods used to increase nail penetration include abrasion of the nail surface by mechanical means or low-powered laser, total nail avulsion by laser, and conventional surgical avulsion.<a class="elsevierStyleCrossRefs" href="#bib0145"><span class="elsevierStyleSup">29,44</span></a></p><p id="par0150" class="elsevierStylePara elsevierViewall">Recent studies have found no association between surgical avulsion and subsequent problems with nail regrowth, and no differences between total and partial avulsion.<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">38,44</span></a> Outcomes improved, however, when surgical avulsion was accompanied by topical occlusive treatment until the nail had regrown completely. Overall, surgical avulsion was found to have similar efficacy to, and no advantage over, medical treatments.<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">38,44</span></a></p><p id="par0155" class="elsevierStylePara elsevierViewall">One of the most promising treatment options is photodynamic therapy. This technique is effective against mucocutaneous candidiasis,<a class="elsevierStyleCrossRefs" href="#bib0225"><span class="elsevierStyleSup">45–47</span></a> onychomycosis caused by <span class="elsevierStyleItalic">Trichophyton rubrum</span>,<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">48–51</span></a> and extensive folliculitis caused by <span class="elsevierStyleItalic">Pityrosporon</span> organisms.<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">52</span></a> The results of photodynamic therapy have, however, been less promising in cases of tinea cruris.<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">53</span></a> We therefore believe that further studies are needed to determine dosages and treatment regimens.</p><p id="par0160" class="elsevierStylePara elsevierViewall">Other alternatives for treating onychomycosis, such as boosted treatments<a class="elsevierStyleCrossRefs" href="#bib0270"><span class="elsevierStyleSup">54,55</span></a> and iontophoresis, are still in the experimental stage.<a class="elsevierStyleCrossRefs" href="#bib0280"><span class="elsevierStyleSup">56,57</span></a></p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Conclusion</span><p id="par0165" class="elsevierStylePara elsevierViewall">In summary, we consider that the expenditure on topical and systemic antifungal agents in Spain is very high. Moreover, we believe that, in most cases, the proper use of conventional drugs makes the use of more expensive drugs unnecessary. In the case of onychomycosis, we believe that the use of the recommended switch therapy could lead to considerable savings.</p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Conflicts of Interest</span><p id="par0170" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:14 [ 0 => array:2 [ "identificador" => "xres96584" "titulo" => "Abstract" ] 1 => array:2 [ "identificador" => "xpalclavsec83742" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "xres96585" "titulo" => "Resumen" ] 3 => array:2 [ "identificador" => "xpalclavsec83743" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Available Treatments Are Well Known But Poorly Used" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "How Much Is Being Spent on Antifungal Agents in Spain?" ] 7 => array:3 [ "identificador" => "sec0020" "titulo" => "First-Line Treatments and Practical Aspects" "secciones" => array:6 [ 0 => array:2 [ "identificador" => "sec0025" "titulo" => "Griseofulvin" ] 1 => array:2 [ "identificador" => "sec0030" "titulo" => "Oral Triazoles" ] 2 => array:2 [ "identificador" => "sec0035" "titulo" => "Topical Azoles" ] 3 => array:2 [ "identificador" => "sec0040" "titulo" => "Allylamines" ] 4 => array:2 [ "identificador" => "sec0045" "titulo" => "Morpholines and Ciclopirox" ] 5 => array:2 [ "identificador" => "sec0050" "titulo" => "Polyenes (Nystatin)" ] ] ] 8 => array:2 [ "identificador" => "sec0055" "titulo" => "Recommendations for Reducing the Duration of Oral Treatment" ] 9 => array:2 [ "identificador" => "sec0060" "titulo" => "Cost-Effectiveness in Specific Situations" ] 10 => array:2 [ "identificador" => "sec0065" "titulo" => "Switch Therapy in Onychomycosis" ] 11 => array:2 [ "identificador" => "sec0070" "titulo" => "Conclusion" ] 12 => array:2 [ "identificador" => "sec0075" "titulo" => "Conflicts of Interest" ] 13 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2011-07-28" "fechaAceptado" => "2012-01-15" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec83742" "palabras" => array:5 [ 0 => "Superficial mycoses" 1 => "Dermatophytoses" 2 => "Candidiasis" 3 => "Therapies" 4 => "Antifungal agents" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec83743" "palabras" => array:5 [ 0 => "Micosis superficiales" 1 => "Dermatofitosis" 2 => "Candidiasis" 3 => "Terapéutica" 4 => "Antifúngicos" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">We review the current treatments available for superficial mycoses and discuss recent developments in pharmacotherapy and the most useful adjuvant treatments. Special emphasis is placed on the proper use of conventional therapies and a number of pharmacoeconomic issues. The review also offers an update on the best treatment choices in particular circumstances. Finally, we discuss some novel contributions found in the literature.</p>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Se revisa la terapéutica disponible actualmente para el tratamiento de las micosis superficiales, las novedades existentes en el campo de la quimioterapia y los tratamientos coadyuvantes más útiles en este terreno. Se hace especial hincapié en el adecuado uso de los tratamientos convencionales y en algunos aspectos farmacoeconómicos relacionados con el tema. Se actualizan los procedimientos terapéuticos más adecuados en circunstancias especiales. Finalmente, se discuten algunas aportaciones novedosas encontradas en la literatura revisada.</p>" ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara">Please cite this article as: Pereiro Ferreirós Jr M, et al. Actualización en el tratamiento de las micosis cutáneas. Actas Dermosifiliogr. 2012;103:778-83.</p>" ] ] "multimedia" => array:3 [ 0 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleBold">Topical</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">10 800 000 units</span><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">€36 060 726.26 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleBold">Gynecological</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">2 400 000 units</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">€8 155.74 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="2" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleBold">Systemic</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">1 700 000 units</span><a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">c</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">€24 636 920.42 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Fluconazole \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">€9 524 603 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Itraconazole \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">€8 429 519 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Terbinafine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">€6 682 798 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab182570.png" ] ] ] "notaPie" => array:3 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara">Official population of Spain (2001 census): 40 847 371.</p>" ] 1 => array:3 [ "identificador" => "tblfn0010" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara">One package of topical antifungal agent for every 4 inhabitants.</p>" ] 2 => array:3 [ "identificador" => "tblfn0015" "etiqueta" => "c" "nota" => "<p class="elsevierStyleNotepara">One package of systemic antifungal agent for every 24 inhabitants.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Estimated Expenditure in Spain on Topical and Systemic Antifungal Agents, Based on Spanish Ministry of Health and Consumer Affairs Data From 2001 Provided in 2007.<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a></p>" ] ] 1 => array:7 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Clinical Presentation \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">First-Line Treatment \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Second-Line Treatment \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Adjuvant Treatment \t\t\t\t\t\t\n \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="4" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Tinea</span></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Pedis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Topical terbinafine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Topical ciclopirox. Topical or oral itraconazole or terbinafine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">FomentationsHand or foot bathsOcclusive dressing \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Cruris \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Topical azole \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Corporis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Topical azole \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Barbae \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Griseofulvin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Imidazole shampoo, fomentations, pH monitoring \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Capitis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Griseofulvin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="4" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Extensive tineas and tineas affecting the glabrous skin of the hands</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Oral terbinafine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Oral itraconazole \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Topical azole \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Inflammatory tineas</span><a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Topical azole \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Topical terbinafine or ciclopirox \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Occlusive dressing combined with topical corticosteroids \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Onychomycosis</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Switch therapy: topical ciclopirox, oral itraconazole, oral terbinafine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Switch therapy: oral itraconazole, oral terbinafine, topical ciclopirox \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Nail avulsionPhotodynamic therapy \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="4" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="4" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Pityriasis versicolor</span></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Extensive \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Oral itraconazole \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Topical terbinafine or ciclopirox \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Imidazole gel, before oral treatment and/or as maintenance therapy \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Localized \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Topical azole \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="4" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Oropharyngeal candidiasis</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Nystatin (polyenes) for mild forms \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Fluconazole for resistant or recurrent forms \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Oral rinse containing bicarbonate/chlorhexidine \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab182572.png" ] ] ] "notaPie" => array:1 [ 0 => array:3 [ "identificador" => "tblfn0020" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara">Inflammatory tineas not belonging to any other category that do not require systemic treatment.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">First-Line Treatments and Adjuvant Therapies.</p>" ] ] 2 => array:7 [ "identificador" => "tbl0015" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Least Expensive \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Most Expensive \t\t\t\t\t\t\n \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Ciclopirox or amorolfine, 1 mo \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Continuous oral itraconazole, 3 mo \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Followed by: oral itraconazole pulse therapy, 3 mo \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Followed by: continuous oral terbinafine, 3 mo \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Followed by: continuous oral terbinafine, 3 mo \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Followed by: topical ciclopirox or amorolfine, 3 mo \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cost for 500 000 patients: €2 091 508 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Cost for 500 000 patients: €5 837 400 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Response rate: 97.9%<a class="elsevierStyleCrossRef" href="#tblfn0030"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Response rate: 96.2%<a class="elsevierStyleCrossRef" href="#tblfn0030"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab182571.png" ] ] ] "notaPie" => array:2 [ 0 => array:3 [ "identificador" => "tblfn0025" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara">The options compared are the 2 switch therapy regimens with the highest response rates.</p>" ] 1 => array:3 [ "identificador" => "tblfn0030" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara">The computer model took into account the response rate for each of the medications used.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Switch Therapy for Onychomycosis: Comparison of Net Cost Per 500 000 Patients.<a class="elsevierStyleCrossRef" href="#tblfn0025"><span class="elsevierStyleSup">a</span></a></p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:57 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "La pitiriasis versicolor y las levaduras del género <span class="elsevierStyleItalic">Malassezia</span>" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "V. Crespo-Erchiga" 1 => "E. Gómez-Moyano" 2 => "M. Crespo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2008" "volumen" => "99" "paginaInicial" => "764" "paginaFinal" => "771" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19091214" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Incidencia de los dermatofitos en España desde 1926 a 1994" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Pereiro Miguens" 1 => "E. Pereiro" 2 => "M. Pereiro Jr." 3 => "M.M. Pereiro-Ferreirós" 4 => "J. Toribio" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "1996" "volumen" => "87" "paginaInicial" => "77" "paginaFinal" => "84" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiology of superficial fungal infections" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M. Ameen" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.clindermatol.2009.12.005" "Revista" => array:6 [ "tituloSerie" => "Clin Dermatol" "fecha" => "2010" "volumen" => "28" "paginaInicial" => "197" "paginaFinal" => "201" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20347663" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Updates on the epidemiology of dermatophyte infections" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C. Seebacher" 1 => "J.P. Bouchara" 2 => "B. Mignon" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11046-008-9100-9" "Revista" => array:6 [ "tituloSerie" => "Mycopathologia" "fecha" => "2008" "volumen" => "166" "paginaInicial" => "335" "paginaFinal" => "352" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18478365" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Aportaciones del comité de la AEM para la estandarización de pruebas de estudio de la sensibilidad <span class="elsevierStyleItalic">in vitro</span> a los antifúngicos: Método de difusión en disco" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Carrillo Muñoz" 1 => "G. Quindós" 2 => "M.P. Arevalo" 3 => "F. Bornay" 4 => "F.J. Cabañes" 5 => "J.B. Casals" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Iberoam Micol" "fecha" => "1996" "volumen" => "13" "paginaInicial" => "S101" "paginaFinal" => "S104" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multicenter survey of in vitro antifungal resistance in yeasts of medical importance isolated from Spanish patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Quindós" 1 => "L. Abarca" 2 => "A. Carrillo" 3 => "P. Arévalo" 4 => "F.J. Bornay" 5 => "J.B. Casals" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Iberoam Micol" "fecha" => "1999" "volumen" => "16" "paginaInicial" => "97" "paginaFinal" => "100" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18473577" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "In vitro susceptibilities of <span class="elsevierStyleItalic">Malassezia</span> species to a new triazole, albaconazole (UR-9825), and other antifungal compounds" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M. Garau" 1 => "M. Pereiro Jr." 2 => "A. Palacio" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Antimicrob Agent Chemother" "fecha" => "2003" "volumen" => "47" "paginaInicial" => "2342" "paginaFinal" => "2344" "itemHostRev" => array:3 [ "pii" => "S0010782408004101" "estado" => "S300" "issn" => "00107824" ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of two methods for antifungal susceptibility testing of Trichophyton rubrum" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "B. Fernández-Torres" 1 => "M. Pereiro Jr." 2 => "J. Guarro" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Eur J Clin Microbiol Infect Dis" "fecha" => "2002" "volumen" => "21" "paginaInicial" => "70" "paginaFinal" => "71" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11913509" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "New antifungal therapies for the treatment of onychomycosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S. Kumar" 1 => "A.B. Kimballt" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Expert Opin Investig Drugs" "fecha" => "2009" "volumen" => "18" "paginaInicial" => "721" "paginaFinal" => "734" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Natural products as antifungal agents against clinically relevant pathogens" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R. Di Santo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1039/b914961a" "Revista" => array:6 [ "tituloSerie" => "Nat Prod Rep" "fecha" => "2010" "volumen" => "27" "paginaInicial" => "1084" "paginaFinal" => "1098" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20485730" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antifúngicos del futuro" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "E. Silva-Lizama" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Cut Iber Lat Am" "fecha" => "2004" "volumen" => "32" "paginaInicial" => "229" "paginaFinal" => "230" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systematic review of topical treatments for fungal infections of the skin and nails of the feet" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "R. Hart" 1 => "S.E.M. Bell-Syer" 2 => "F. Crawford" 3 => "D.J. Torgerson" 4 => "P. Young" 5 => "I. Russell" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "1999" "volumen" => "319" "paginaInicial" => "79" "paginaFinal" => "82" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10398626" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A.K. Gupta" 1 => "J.E. Ryder" 2 => "A.M. Johnson" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1046/j.1365-2133.2003.05728.x" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2004" "volumen" => "150" "paginaInicial" => "537" "paginaFinal" => "544" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15030339" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "H.L. Tey" 1 => "A.S. Tan" 2 => "Y.C. Chan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2010.02.048" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2011" "volumen" => "64" "paginaInicial" => "663" "paginaFinal" => "670" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21334096" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antifúngicos disponibles para el tratamiento de las micosis ungueales" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A.J. Carrillo-Muñoz" 1 => "C. Tur-Tur" 2 => "J.M. Hernández-Molina" 3 => "P. Santos" 4 => "D. Cárdenes" 5 => "G. Giusiano" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.riam.2010.01.007" "Revista" => array:6 [ "tituloSerie" => "Rev Iberoam Micol" "fecha" => "2010" "volumen" => "27" "paginaInicial" => "49" "paginaFinal" => "56" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20346303" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacoeconomics – an aid to better decision-making" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R. Arenas-Guzmán" 1 => "A. Tosti" 2 => "R. Hay" 3 => "E. Haneke" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1468-3083.2005.01285.x" "Revista" => array:6 [ "tituloSerie" => "JEADV" "fecha" => "2005" "volumen" => "19" "paginaInicial" => "34" "paginaFinal" => "39" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16120204" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Pereiro Ferreirós M. Coste-eficacia en el tratamiento de las micosis cutáneas. XIX Reunión Clínica Internacional de Dermatología de Barcelona (28 February-1 March 2008). Barcelona; 2008." ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Review of antifungal therapy, part <span class="elsevierStyleSmallCaps">ii</span>: Treatment rationale, including specific patient populations" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "R. Baran" 1 => "R.J. Hay" 2 => "J.I. Garduno" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Dermatol Treat" "fecha" => "2008" "volumen" => "19" "paginaInicial" => "168" "paginaFinal" => "175" ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Drug delivery strategies for improved azole antifungal action" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "W. Yang" 1 => "N.P. Wiederhold" 2 => "R.O. Williams" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1517/17425240802457188" "Revista" => array:6 [ "tituloSerie" => "Expert Opin Drug Deliv" "fecha" => "2008" "volumen" => "5" "paginaInicial" => "1199" "paginaFinal" => "1216" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18976131" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Current concepts in systemic and topical therapy for superficial mycoses" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "L.E. Millikan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.clindermatol.2009.12.016" "Revista" => array:6 [ "tituloSerie" => "Clin Dermatol" "fecha" => "2010" "volumen" => "28" "paginaInicial" => "212" "paginaFinal" => "216" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20347665" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Griseofulvin" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M. Develoux" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Dermatol Venereol" "fecha" => "2001" "volumen" => "128" "paginaInicial" => "1317" "paginaFinal" => "1325" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11908134" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tinea capitis en el área sanitaria de Santiago de Compostela" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "B. Monteagudo" 1 => "M. Pereiro Jr." 2 => "C. Peteiro" 3 => "J. Toribio" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2003" "volumen" => "94" "paginaInicial" => "598" "paginaFinal" => "602" ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tiña inflamatoria de la ingle en una mujer por <span class="elsevierStyleItalic">T. mentagrophytes</span> var. <span class="elsevierStyleItalic">interdigitale</span>" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M. Gómez Vázquez" 1 => "D. Sánchez-Aguilar" 2 => "M. Pereiro Jr." 3 => "J. Toribio" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2002" "volumen" => "93" "paginaInicial" => "461" "paginaFinal" => "463" ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systemic antifungal therapy for tinea capitis in children" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "U. González" 1 => "T. Seaton" 2 => "G. Bergus" 3 => "J. Jacobson" 4 => "C. Martínez-Monzón" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Cochrane Database Syst Rev" "fecha" => "2007" "volumen" => "17" "paginaInicial" => "C D004685" ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0125" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vulvovaginitis de repetición. Valoración diagnóstica y manejo terapéutico" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Ramírez-Santos" 1 => "M. Pereiro Jr." 2 => "J. Toribio" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2008" "volumen" => "99" "paginaInicial" => "190" "paginaFinal" => "198" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18358194" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0010782407004222" "estado" => "S300" "issn" => "00107824" ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0130" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Plantar hyperkeratosis due to Fusarium verticillioides in a patient with malignancy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M. Pereiro Jr." 1 => "J. Labandeira" 2 => "J. Toribio" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Exp Dermatol" "fecha" => "1999" "volumen" => "24" "paginaInicial" => "175" "paginaFinal" => "178" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10354173" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0135" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Chronic infection due to Fusarium oxysporum mimicking lupus vulgaris: Case report and review of cutaneous involvement in fusariosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Pereiro Jr." 1 => "M.T. Abalde" 2 => "A. Zulaica" 3 => "J.L. Caeiro" 4 => "A. Flórez" 5 => "C. Peteiro" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Acta Derm Venereol" "fecha" => "2001" "volumen" => "81" "paginaInicial" => "51" "paginaFinal" => "53" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11411917" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0140" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The vulvar skin microenvironment: Impact of tight-fitting underwear on microclimate, pH and microflora" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "B. Runeman" 1 => "G. Rybo" 2 => "U. Forsgren-Brusk" 3 => "O. Larkö" 4 => "P. Larsson" 5 => "J. Faergemann" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/00015550410024562" "Revista" => array:7 [ "tituloSerie" => "Acta Derm Venereol" "fecha" => "2005" "volumen" => "85" "paginaInicial" => "118" "paginaFinal" => "122" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15823903" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0010782410003896" "estado" => "S300" "issn" => "00107824" ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0145" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Overcoming the nail barrier: A systematic investigation of ungual chemical penetration enhancement" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.B. Browna" 1 => "R.H. Khengarc" 2 => "R.B. Turnerb" 3 => "B. Forbesc" 4 => "M.J. Traynora" 5 => "C.R.G. Evans" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Int J Pharmaceutic" "fecha" => "2009" "volumen" => "370" "paginaInicial" => "61" "paginaFinal" => "67" ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0150" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Transungual drug delivery: Current status" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R. Elkeeb" 1 => "A. AliKhanb" 2 => "L. Elkeebc" 3 => "X. Huia" 4 => "H.T. Maibacha" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Int J Pharmaceutic" "fecha" => "2010" "volumen" => "384" "paginaInicial" => "1" "paginaFinal" => "8" ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0155" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "B. Havlickova" 1 => "M. Friedrich" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1439-0507.2008.01615.x" "Revista" => array:6 [ "tituloSerie" => "Mycoses" "fecha" => "2008" "volumen" => "51" "paginaInicial" => "16" "paginaFinal" => "26" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18783560" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0160" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tinea pedis: clinical experience and efficacy of short treatment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "E.G.V. Evans" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Dermatology" "fecha" => "1997" "volumen" => "194" "paginaInicial" => "3" "paginaFinal" => "6" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9154392" "web" => "Medline" ] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0165" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tinea pedis causada por <span class="elsevierStyleItalic">Trichophyton violaceum</span>" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "B. Monteagudo" 1 => "M. Pereiro Ferreirós Jr." 2 => "V. Fernández-Redondo" 3 => "J. Toribio" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2002" "volumen" => "93" "paginaInicial" => "35" "paginaFinal" => "37" ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0170" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Estudio de satisfacción con el tratamiento de las micosis en extremidades con terbinafina (SETTA)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M. Sánchez-Schmidt" 1 => "S. Giménez-Jovani" 2 => "J. Peyrí-Rey" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2005" "volumen" => "96" "paginaInicial" => "285" "paginaFinal" => "290" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16476388" "web" => "Medline" ] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0175" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "German Contact Dermatitis Research Group (DKG); Information Network of Departments of Dermatology (IVDK). Contact allergy to topical antifungal agents" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C.A. de Pádua" 1 => "W. Uter" 2 => "J. Geier" 3 => "A. Schnuch" 4 => "I. Effendy" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1398-9995.2008.01728.x" "Revista" => array:6 [ "tituloSerie" => "Allergy" "fecha" => "2008" "volumen" => "63" "paginaInicial" => "946" "paginaFinal" => "947" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18588567" "web" => "Medline" ] ] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0180" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Candidiasis mucocutáneas" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D. González-Vilas" 1 => "M. Pereiro Jr." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Piel" "fecha" => "2008" "volumen" => "23" "paginaInicial" => "464" "paginaFinal" => "474" ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0185" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of hydration on the permeation of ketoconazole through human nail plate in vitro" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "H.B. Gunt" 1 => "G.B. Kasting" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ejps.2007.07.009" "Revista" => array:6 [ "tituloSerie" => "Eur J Pharm Sci" "fecha" => "2007" "volumen" => "32" "paginaInicial" => "254" "paginaFinal" => "260" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17928205" "web" => "Medline" ] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0190" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy of debridement alone versus debridement combined with topical antifungal nail lacquer for the treatment of pedal onychomycosis: a randomized, controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "D.S. Malay" 1 => "S. Yi" 2 => "P. Borowsky" 3 => "M.S. Downey" 4 => "A.J. Mlodzienski" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Foot Ank Surg" "fecha" => "2009" "volumen" => "48" "paginaInicial" => "294" "paginaFinal" => "308" ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0195" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacoeconomic analysis of sequential treatment pathways in the treatment of onychomycosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "L.E. Frankum" 1 => "B. Nightengale" 2 => "C.L. Russo" 3 => "M. Sarnes" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Managed Care Interface" "fecha" => "2005" "volumen" => "18" "paginaInicial" => "55" "paginaFinal" => "63" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16405226" "web" => "Medline" ] ] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0200" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Onychomycosis of the feet: treatment with griseofulvin" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R.M. Reisner" 1 => "R.S. Homer" 2 => "V. Newcomer" 3 => "T.H. Sternberg" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Calif Med" "fecha" => "1960" "volumen" => "93" "paginaInicial" => "217" "paginaFinal" => "223" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/13740670" "web" => "Medline" ] ] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0205" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Kontinuierliche oder diskontinuierliche Therapie der Onychomykosen mit resorptionsaktivem Griseofulvin?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "C. Seebacher" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Mykosen" "fecha" => "1966" "volumen" => "9" "paginaInicial" => "126" "paginaFinal" => "129" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/4224979" "web" => "Medline" ] ] ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0210" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500<span class="elsevierStyleHsp" style=""></span>mg day) 1 for a week" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Y. Takahata" 1 => "M. Hiruma" 2 => "Y. Shiraki" 3 => "Y. Tokuhisa" 4 => "T. Sugita" 5 => "M. Muto" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1439-0507.2008.01531.x" "Revista" => array:6 [ "tituloSerie" => "Mycoses" "fecha" => "2009" "volumen" => "52" "paginaInicial" => "72" "paginaFinal" => "76" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18444971" "web" => "Medline" ] ] ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0215" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "A.K. Gupta" 1 => "L.E. Lynch" 2 => "N. Kogan" 3 => "E.A. Cooper" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1468-3083.2008.03036.x" "Revista" => array:6 [ "tituloSerie" => "J Eur Acad Dermatol Venereol" "fecha" => "2009" "volumen" => "23" "paginaInicial" => "256" "paginaFinal" => "262" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19438818" "web" => "Medline" ] ] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0220" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C. Grover" 1 => "S. Bansal" 2 => "S. Nanda" 3 => "B.S.N. Reddy" 4 => "V. Kumar" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2133.2007.08014.x" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2007" "volumen" => "157" "paginaInicial" => "364" "paginaFinal" => "368" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17573877" "web" => "Medline" ] ] ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0225" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of the photodynamic fungicidal efficacy of methylene blue, toluidine blue, malachite green and low-power laser irradiation alone against <span class="elsevierStyleItalic">Candida albicans</span>" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "R. Souza" 1 => "J. Campos Junqueira" 2 => "R.D. Rossoni" 3 => "C.A. Pereira" 4 => "E. Munin" 5 => "A.O.C. Jorge" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10103-009-0706-z" "Revista" => array:7 [ "tituloSerie" => "Lasers Med Sci" "fecha" => "2010" "volumen" => "25" "paginaInicial" => "385" "paginaFinal" => "389" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19579004" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0140673600026994" "estado" => "S300" "issn" => "01406736" ] ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0230" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Susceptibility of Candida species to photodynamic effects of Photofrin" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.M. Bliss" 1 => "C.E. Bigelow" 2 => "T.H. Foster" 3 => "C.G. Haidaris" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Antimicrob Agent Chemother" "fecha" => "2004" "volumen" => "48" "paginaInicial" => "2000" "paginaFinal" => "2006" ] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib0235" "etiqueta" => "47" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Susceptibility of <span class="elsevierStyleItalic">Candida albicans</span> to photodynamic therapy in a murine model of oral candidosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E. García de Oliveira Mima" 1 => "A. Cláudia Pavarina" 2 => "L. Nordi Dovigo" 3 => "C.E. Vergani" 4 => "C.A. Souza Costa" 5 => "C. Kurachi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.tripleo.2009.10.006" "Revista" => array:6 [ "tituloSerie" => "Oral Surg Oral Med Oral Pathol Oral Radiol Endod" "fecha" => "2010" "volumen" => "109" "paginaInicial" => "392" "paginaFinal" => "401" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20060338" "web" => "Medline" ] ] ] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib0240" "etiqueta" => "48" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Successful treatment of toenail onychomycosis with photodynamic therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "D. Watanabe" 1 => "C. Kawamura" 2 => "Y. Masuda" 3 => "Y. Akita" 4 => "Y. Tamada" 5 => "Y. Matsumoto" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archdermatol.2007.17" "Revista" => array:7 [ "tituloSerie" => "Arch Dermatol" "fecha" => "2008" "volumen" => "144" "paginaInicial" => "19" "paginaFinal" => "21" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18209164" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0010782410000405" "estado" => "S300" "issn" => "00107824" ] ] ] ] ] ] ] 48 => array:3 [ "identificador" => "bib0245" "etiqueta" => "49" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Photodynamic therapy of onychomycosis caused by Trichophyton rubrum" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "B.M. Piraccini" 1 => "G. Rech" 2 => "A. Tosti" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2008.06.015" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2008" "volumen" => "59" "paginaInicial" => "S75" "paginaFinal" => "S76" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19119130" "web" => "Medline" ] ] ] ] ] ] ] ] 49 => array:3 [ "identificador" => "bib0250" "etiqueta" => "50" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by <span class="elsevierStyleItalic">Trichophyton rubrum</span>: preliminary results of a single-centre open trial" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "E. Sotiriou" 1 => "T. Koussidou-Ermonti" 2 => "G. Chaidemenos" 3 => "Z. Apalla" 4 => "D. Ioannides" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2340/00015555-0811" "Revista" => array:6 [ "tituloSerie" => "Acta Derm Venereol" "fecha" => "2009" "volumen" => "90" "paginaInicial" => "216" "paginaFinal" => "217" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20169321" "web" => "Medline" ] ] ] ] ] ] ] ] 50 => array:3 [ "identificador" => "bib0255" "etiqueta" => "51" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of refractory fingernail onychomycosis caused by non dermatophyte molds with methylaminolevulinate photodynamic therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Y. Gilaberte" 1 => "C. Aspiroz" 2 => "M.P. Martes" 3 => "V. Alcalde" 4 => "A. Espinel-Ingroff" 5 => "A. Rezusta" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2010.06.008" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2011" "volumen" => "65" "paginaInicial" => "669" "paginaFinal" => "671" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21839332" "web" => "Medline" ] ] ] ] ] ] ] ] 51 => array:3 [ "identificador" => "bib0260" "etiqueta" => "52" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "5-Aminolevulininic acid photodynamic therapy treatment for tinea cruris caused by Trichophyton rubrum: report of 10 cases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "E. Sotiriou" 1 => "D. Panagiotidou" 2 => "D. Ioannides" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1468-3083.2008.02880.x" "Revista" => array:6 [ "tituloSerie" => "JEADV" "fecha" => "2009" "volumen" => "23" "paginaInicial" => "341" "paginaFinal" => "342" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18637974" "web" => "Medline" ] ] ] ] ] ] ] ] 52 => array:3 [ "identificador" => "bib0265" "etiqueta" => "53" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Photodynamic therapy: new treatment for recalcitrant <span class="elsevierStyleItalic">Malassezia</span> folliculitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.W. Lee" 1 => "B.J. Kim" 2 => "M.N. Kim" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Laser Surg Med" "fecha" => "2010" "volumen" => "42" "paginaInicial" => "192" "paginaFinal" => "196" ] ] ] ] ] ] 53 => array:3 [ "identificador" => "bib0270" "etiqueta" => "54" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The boosted antifungal topical treatment (BATT) for onychomycosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G.E. Pierard" 1 => "C. Pierard-Franchimont" 2 => "J.E. Arrese" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Med Mycol" "fecha" => "2000" "volumen" => "38" "paginaInicial" => "391" "paginaFinal" => "392" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11092387" "web" => "Medline" ] ] ] ] ] ] ] ] 54 => array:3 [ "identificador" => "bib0275" "etiqueta" => "55" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Onychomycoses récalcitrantes et le ‘low-coast BOAT’ au fluconazole" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "V. Goffin" 1 => "J.E. Arrese" 2 => "G.E. Pierard" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Skin" "fecha" => "2002" "volumen" => "5" "paginaInicial" => "145" "paginaFinal" => "147" "itemHostRev" => array:3 [ "pii" => "S001078240800139X" "estado" => "S300" "issn" => "00107824" ] ] ] ] ] ] ] 55 => array:3 [ "identificador" => "bib0280" "etiqueta" => "56" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Iontophoretically enhanced ciclopirox delivery into and across human nail plate" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J. Hao" 1 => "K.A. Smith" 2 => "S.K. Li" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jps.21664" "Revista" => array:7 [ "tituloSerie" => "J Pharm Sci" "fecha" => "2009" "volumen" => "98" "paginaInicial" => "3608" "paginaFinal" => "3616" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19117048" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0010782408005180" "estado" => "S300" "issn" => "00107824" ] ] ] ] ] ] ] 56 => array:3 [ "identificador" => "bib0285" "etiqueta" => "57" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An ex vivo toe model used to assess applicators for the iontophoretic ungual delivery of terbinafine" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.B. Nair" 1 => "H.D. Kim" 2 => "S.P. Davis" 3 => "R. Etheredge" 4 => "M. Barsness" 5 => "P.M. Friden" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Pharmaceutical Res" "fecha" => "2009" "volumen" => "26" "paginaInicial" => "2194" "paginaFinal" => "2201" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010300000009/v1_201304241357/S1578219012002752/v1_201304241357/en/main.assets" "Apartado" => array:4 [ "identificador" => "6177" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Reviews" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010300000009/v1_201304241357/S1578219012002752/v1_201304241357/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219012002752?idApp=UINPBA000044" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 19 | 13 | 32 |
2024 October | 117 | 57 | 174 |
2024 September | 112 | 36 | 148 |
2024 August | 149 | 63 | 212 |
2024 July | 108 | 43 | 151 |
2024 June | 115 | 45 | 160 |
2024 May | 116 | 53 | 169 |
2024 April | 77 | 32 | 109 |
2024 March | 242 | 84 | 326 |
2024 February | 131 | 41 | 172 |
2024 January | 99 | 39 | 138 |
2023 December | 110 | 24 | 134 |
2023 November | 120 | 36 | 156 |
2023 October | 103 | 24 | 127 |
2023 September | 85 | 52 | 137 |
2023 August | 65 | 23 | 88 |
2023 July | 84 | 45 | 129 |
2023 June | 84 | 41 | 125 |
2023 May | 98 | 75 | 173 |
2023 April | 68 | 63 | 131 |
2023 March | 64 | 38 | 102 |
2023 February | 59 | 29 | 88 |
2023 January | 40 | 35 | 75 |
2022 December | 45 | 35 | 80 |
2022 November | 20 | 25 | 45 |
2022 October | 26 | 25 | 51 |
2022 September | 18 | 45 | 63 |
2022 August | 37 | 22 | 59 |
2022 July | 35 | 36 | 71 |
2022 June | 60 | 28 | 88 |
2022 May | 62 | 43 | 105 |
2022 April | 94 | 42 | 136 |
2022 March | 103 | 50 | 153 |
2022 February | 121 | 43 | 164 |
2022 January | 87 | 50 | 137 |
2021 December | 74 | 49 | 123 |
2021 November | 84 | 51 | 135 |
2021 October | 70 | 47 | 117 |
2021 September | 76 | 41 | 117 |
2021 August | 69 | 29 | 98 |
2021 July | 69 | 35 | 104 |
2021 June | 82 | 63 | 145 |
2021 May | 88 | 34 | 122 |
2021 April | 312 | 45 | 357 |
2021 March | 141 | 39 | 180 |
2021 February | 124 | 31 | 155 |
2021 January | 96 | 21 | 117 |
2020 December | 69 | 15 | 84 |
2020 November | 48 | 20 | 68 |
2020 October | 78 | 19 | 97 |
2020 September | 56 | 8 | 64 |
2020 August | 40 | 21 | 61 |
2020 July | 37 | 12 | 49 |
2020 June | 33 | 35 | 68 |
2020 May | 33 | 23 | 56 |
2020 April | 32 | 19 | 51 |
2020 March | 36 | 18 | 54 |
2020 February | 8 | 3 | 11 |
2020 January | 4 | 0 | 4 |
2019 December | 8 | 5 | 13 |
2019 November | 4 | 1 | 5 |
2019 October | 0 | 6 | 6 |
2019 September | 10 | 1 | 11 |
2019 August | 4 | 4 | 8 |
2019 July | 4 | 1 | 5 |
2019 June | 6 | 38 | 44 |
2019 May | 4 | 77 | 81 |
2019 April | 2 | 33 | 35 |
2019 March | 2 | 11 | 13 |
2019 February | 2 | 6 | 8 |
2019 January | 1 | 0 | 1 |
2018 December | 5 | 11 | 16 |
2018 November | 0 | 1 | 1 |
2018 October | 1 | 0 | 1 |
2018 September | 6 | 3 | 9 |
2018 August | 0 | 1 | 1 |
2018 July | 2 | 0 | 2 |
2018 June | 0 | 3 | 3 |
2018 May | 0 | 2 | 2 |
2018 April | 0 | 1 | 1 |
2018 March | 14 | 5 | 19 |
2018 February | 56 | 7 | 63 |
2018 January | 64 | 9 | 73 |
2017 December | 80 | 5 | 85 |
2017 November | 56 | 9 | 65 |
2017 October | 68 | 8 | 76 |
2017 September | 54 | 8 | 62 |
2017 August | 44 | 11 | 55 |
2017 July | 51 | 19 | 70 |
2017 June | 46 | 19 | 65 |
2017 May | 48 | 22 | 70 |
2017 April | 58 | 20 | 78 |
2017 March | 35 | 10 | 45 |
2017 February | 99 | 22 | 121 |
2017 January | 63 | 15 | 78 |
2016 December | 78 | 17 | 95 |
2016 November | 88 | 15 | 103 |
2016 October | 93 | 25 | 118 |
2016 September | 106 | 32 | 138 |
2016 August | 86 | 15 | 101 |
2016 July | 61 | 16 | 77 |
2016 June | 9 | 14 | 23 |
2016 May | 6 | 10 | 16 |
2016 April | 10 | 3 | 13 |
2016 March | 16 | 16 | 32 |
2016 February | 9 | 20 | 29 |
2016 January | 7 | 11 | 18 |
2015 December | 8 | 7 | 15 |
2015 November | 12 | 16 | 28 |
2015 October | 18 | 6 | 24 |
2015 September | 13 | 3 | 16 |
2015 August | 19 | 6 | 25 |
2015 July | 75 | 1 | 76 |
2015 June | 70 | 14 | 84 |
2015 May | 120 | 10 | 130 |
2015 April | 89 | 16 | 105 |
2015 March | 80 | 13 | 93 |
2015 February | 50 | 9 | 59 |
2015 January | 52 | 19 | 71 |
2014 December | 50 | 8 | 58 |
2014 November | 45 | 10 | 55 |
2014 October | 26 | 4 | 30 |
2014 September | 17 | 1 | 18 |
2014 August | 18 | 5 | 23 |
2014 July | 24 | 3 | 27 |
2014 June | 29 | 8 | 37 |
2014 May | 30 | 8 | 38 |
2014 April | 23 | 4 | 27 |
2014 March | 18 | 14 | 32 |
2014 February | 16 | 15 | 31 |
2014 January | 19 | 19 | 38 |
2013 December | 67 | 15 | 82 |
2013 November | 29 | 19 | 48 |
2013 October | 10 | 17 | 27 |
2013 September | 13 | 10 | 23 |
2013 August | 16 | 29 | 45 |
2013 July | 9 | 42 | 51 |
2013 June | 6 | 35 | 41 |
2013 May | 18 | 43 | 61 |
2013 April | 7 | 40 | 47 |
2013 March | 17 | 24 | 41 |
2013 February | 33 | 15 | 48 |
2013 January | 41 | 16 | 57 |
2012 December | 22 | 8 | 30 |
2012 November | 1 | 1 | 2 |